ArticleScientific reports2026
Integrated computational and in vitro analysis reveals the toxic mechanisms of PFAS in female diminished ovarian reserve.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) are a class of anthropogenic organic compounds ubiquitous in the environment. Growing evidence has underscored these associated health risks. Diminished ovarian reserve (DOR), which is characterized by a decline in oocyte quantity and quality, is a significant cause of female infertility. However, the role of PFAS in the pathogenesis of DOR remains unclear. This study integrated network toxicology, machine learning, molecular docking, and molecular dynamics (MD) simulations to investigate the mechanisms of PFAS on DOR, with subsequent validation using KGN cells. Multi-database screening identified 35 candidate targets. Gene Ontology and KEGG enrichment analyses revealed that PFAS perturb pathways governing cell proliferation and differentiation, immune-inflammatory responses, and hormone signaling. Furthermore, we identified three core targets by integrating the GEO database analysis, and machine learning. Single-gene GSEA elucidated multi-pathway regulatory mechanisms. Molecular docking demonstrated strong binding affinities between PFAS and these targets, while MD simulations confirmed the structural stability of the resulting complexes. PFAS exposure induces dose- and time-dependent cytotoxicity and oxidative stress in KGN cells in vitro. It activates apoptotic signaling via BAX upregulation and Bcl-2 downregulation and accelerates oxidative stress by suppressing glutathione S-transferase P1 (GSTP1) and peroxiredoxin 5 (PRDX5) expression. Additionally, PFAS impair ovarian reserve function by inhibiting the synthesis and secretion of anti-Müllerian hormone (AMH) and inhibin B (INHB). Notably, TGFBR1 upregulation suggests the activation of pro-fibrotic signaling markers, further compromising ovarian function. Our findings propose a potential mechanistic framework wherein PFAS may contribute to DOR progression by correlating with apoptosis, inducing oxidative stress, suppressing reserve markers, and activating fibrotic pathways. This study provides novel insights into the pathogenesis of PFAS-associated DOR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.